This is a Abuja, Nigeria news story, published by VOA, that relates primarily to Gavi news.
For more Abuja, Nigeria news, you can click here:
more Abuja, Nigeria newsFor more Gavi news, you can click here:
more Gavi newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from VOA, you can click here:
more news from VOAOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
malaria vaccination campaign. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest global malaria cases news, malaria rollout news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
R21 malaria vaccineVOA
•
88% Informative
The first 846,000 doses of the R21 malaria vaccine arrived in Abuja, Nigeria , on Thursday .
The country accounts for about 27% of global malaria cases, according to WHO .
The government is covering part of the vaccine costs, with global vaccine group Gavi and international partners funding the rest.
VR Score
92
Informative language
93
Neutral language
60
Article tone
semi-formal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
8
Source diversity
3
Affiliate links
no affiliate links